Category: snoring and apnea

Why PTSD Patients Should be Tested for Obstructive Sleep Apnea 0

Why PTSD Patients Should be Tested for Obstructive Sleep Apnea

Study shows a correlation between PAP therapy in post-traumatic stress disorder patients with comorbid sleep apnea and lessened insomnia severity.

Insomnia is the most common complaint expressed by post-traumatic stress disorder (PTSD) patients. While it’s not surprising that people who have experienced trauma may have difficulty with sleep, the appropriate treatment approach may not be so obvious.

Many PTSD patients may also be experiencing co-occurring obstructive sleep apnea (OSA), which could be contributing to insomnia symptoms. If the OSA is not detected, then these patients may continue to experience what may be preventable symptoms, says Barry Krakow, MD, a sleep specialist at Maimonides Sleep Arts & Sciences in Albuquerque, New Mexico.

In a retrospective review of patient charts, Krakow and a team of other researchers found a correlation between a decrease in insomnia severity and PAP therapy. Results of the nonrandomized study were published in the journal Military Medical Research.

“We can’t take for granted that we know why patients with PTSD are having sleep problems,” says Krakow, a co-author.

According to Krakow, insomnia and PTSD,—commonly

Smartphone-based Diagnostic Test for Respiratory Disease Earns CE Mark Approval 0

Smartphone-based Diagnostic Test for Respiratory Disease Earns CE Mark Approval

Respiratory diagnostics company ResApp Health Ltd has received CE Mark approval for ResAppDx‑EU version 2, the latest version of its smartphone-based diagnostic test for respiratory disease—which now addresses both adults and children.

This CE Mark approval is an extension of the existing CE Mark approval for ResAppDx-EU, adding the ability to test adults for lower respiratory tract disease, pneumonia, asthma exacerbation and chronic obstructive pulmonary disease (COPD) exacerbation. In August, ResApp received CE Mark approval for its pediatric software. CE Mark certification indicates that ResAppDx-EU version 2 meets the essential requirements of all the applicable European regulations as a class IIa medical device and allows for its sale throughout the European Economic Area.

ResApp’s cough-based diagnostic algorithms have been shown in clinical studies to accurately diagnose the most common adult and pediatric acute respiratory diseases when compared with a panel of experienced clinicians.

ResAppDx-EU version 2 is a mobile software application to be used by clinicians for the diagnosis of lower respiratory tract disease, croup (in children only), pneumonia, asthma exacerbation/reactive airway disease, COPD exacerbation (in adults only), and bronchiolitis

The Snoring Mouthpiece Review Issues Blog Post On Humidifiers And Snore RX For Snorers 0

The Snoring Mouthpiece Review Issues Blog Post On Humidifiers And Snore RX For Snorers

The Snoring Mouthpiece Review has announced that they have published a new blog post on how humidifiers and snoring mouthpieces like SnoreRX can help snorers. The blog post is titled, “Humidifier: A Great Gift Even For A Snorer,” and explains why a humidifier can be a great gift idea for a friend or family member who snores. By introducing a moderate amount of moisture into the air, a humidifier can help the snorer relax and have a sound sleep that prevents snoring.

Steve Walker, author of the blog post, says, “A humidifier does more than just provide a spa-like ambiance to a room. It’s actually pretty useful to have a humidifier especially during the winter season.”

He adds, “It’s a practical gift because of the many uses of this particular electronic device. Aside from adding moisture in the air, the humidifier can also help relieve symptoms of different allergies, prevent dry skin, prevent babies from falling sick, and prevent snoring.”

According to the article, the moist air provided by the humidifier soothes the tissues at the back of the throat. …

ResMed Celebrates 30th Anniversary, 20 Years Listed on the New York Stock Exchange by Ringing The Opening Bell 0

ResMed Celebrates 30th Anniversary, 20 Years Listed on the New York Stock Exchange by Ringing The Opening Bell

ResMed CEO Mick Farrell will ring the opening bell at the New York Stock Exchange on Monday, Sept. 30, 2019, to celebrate 20 years of being listed on the New York Stock Exchange and to commemorate ResMed’s 30th anniversary.

Farrell will be joined on the bell podium with other members of the ResMed management team, according to a statement from the company.

Founded in 1989, ResMed began as ResCare, a management buy-out of sleep apnea technology from Baxter Healthcare. Today, ResMed is a software-driven medical device company with over 4.5 billion nights of medical sleep and respiratory care data and over 10 million 100% cloud connectable medical devices in the market.

“From a single $1.25 million investment, ResMed has transformed into a $28 billion (US$19 billion) connected health leader, changing over 100 million lives a year with either a cloud-connected medical device or through software support of an out-of-hospital care agency,” says Farrell in a statement.

“I’m proud to be one of 7,500-plus ResMedians worldwide dedicated to improving the quality of so many lives, and one of countless investors

Philips Consumer Sleep Products Suite Aims to “Address 80% of All Sleep Issues” 0

Philips Consumer Sleep Products Suite Aims to “Address 80% of All Sleep Issues”

Revealed at the CES tradeshow in January 2019, Philips expanded SmartSleep suite of consumer-facing sleep solutions is now available in the United States. The products address sleep issues such as difficulty falling asleep, snoring, and simply not getting enough quality sleep. By expanding its suite of consumer sleep solutions, Philips states that its aim is to ultimately address 80% of all sleep issues globally.

“Everyone sleeps, but unfortunately sleep doesn’t come easily for everyone. There are a host of issues that impact sleep—from trouble falling asleep to snoring to chronic conditions like sleep apnea,” says Mark Michels, business leader, Healthy Sleep Solutions at Philips, in a release. “Using our nearly 40 years of deep clinical expertise in sleep technology, we continue to enhance the solutions available for people who experience common issues that negatively impact the quality of their sleep. Our suite of solutions aims to provide consumers with access to clinically backed innovations that will help them get a better night’s sleep to achieve more productive days ahead, while also increasing awareness to the importance of sleep health. All

Sleep as a Vital Sign: Kristina Weaver, EMT-P, RPSGT 0

Sleep as a Vital Sign: Kristina Weaver, EMT-P, RPSGT

Kristina Weaver, EMT-P, RPSGT, ensures medical center colleagues across all specialties play the sleep advocate.

By Greg Thompson | Photography by Dani Nichol Photography

”KristinaWeaverSleepCenter”

Kristina Weaver, EMT-P, RPSGT, cares deeply about her patients, but she’d rather not see them back at Parrish Healthcare. As director of Care Navigation for the Sleep Navigator/Educator Program at the Titusville, Fla, health system, Weaver has managed a 30% reduction in readmissions for newly identified sleep apnea patients over the last four years,1 a result of healthier patients with positive outcomes.

The improvement comes courtesy of what Weaver calls a more person-centered approach, with screening and education throughout the continuum of care. A person-centered approach gets patients actively involved in their own care, helping them take ownership of their treatment.

“If you have sleep apnea, you cannot effectively treat other comorbid conditions,” Weaver explains. “Take heart failure as an example. When a patient comes into the hospital with left ventricular heart failure and [has] untreated sleep apnea, that left ventricle has to work even harder because it lacks oxygen due to the sleep apnea.

Bongo Rx Preferred Over Traditional CPAP to Treat Sleep Apnea, Survey Shows 0

Bongo Rx Preferred Over Traditional CPAP to Treat Sleep Apnea, Survey Shows

According to a recent Qualtrics Survey conducted September 4 though September 11, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA-cleared Bongo Rx over traditional CPAP therapy to treat their obstructive sleep apnea when given the choice.

The Bongo Rx is a nasal device that requires no CPAP machine, CPAP mask, CPAP hose, bulky headgear, electricity or battery power.

The survey results highlight this new sleep apnea therapy device when compared to traditional CPAP machines and masks. Industry experts estimate that approximately 50% of CPAP patients on average will eventually abandon their CPAP therapy and become non-compliant.

“I feel the results of this Qualtrics Survey reflect that mild to moderate OSA sufferers want a simple and effective alternative to traditional CPAP. Over 70% of the respondents in this survey chose Bongo Rx. It’s gratifying that years of effort by our team to develop the Bongo Rx have yielded such a great outcome,” Bruce Sher, president of AirAvant Medical, maker of the Bongo Rx, says in a statement.

Blood Pressure Increases With Severity of Obstructive Sleep Apnea in Resistant Hypertension 0

Blood Pressure Increases With Severity of Obstructive Sleep Apnea in Resistant Hypertension

Obstructive sleep apnea is highly prevalent and more severe disease appears to be associated with higher blood pressure among patients with resistant hypertension, a recent study suggests.

“We believe that OSA plays an important role in the pathogenesis and prognosis of patients with resistant hypertension,” Mireia Dalmases Cleries, MD, a pulmonologist and sleep researcher at the Hospital Universitari Arnau de Vilanova, said in a press release. “Our study shows a dose-response association between OSA severity and blood pressure, especially during the nighttime period.”

Dalmases Cleries and colleagues evaluated 284 patients with resistant hypertension from three countries recruited between April 2016 and July 2018 as an ancillary study to the SARAH study — a multicenter, international, prospective, observational cohort study measuring the effect of OSA and CPAP on cardiovascular outcomes among patients with resistant hypertension. Only patients aged 18 to 75 years with a diagnosis of resistant hypertension confirmed via 24-hour ambulatory BP monitoring were included. Patients with life expectancy less than 1 year, undergoing current CPAP treatment or with resistant hypertension secondary to an endocrinological cause, drug treatment, renal artery

Sleep Apnea Severity Shows Dose-response Association to Blood Pressure 0

Sleep Apnea Severity Shows Dose-response Association to Blood Pressure

In patients with high blood pressure resistant to treatment who also have obstructive sleep apnea (OSA), the more severe their OSA, the higher their blood pressure, according to new research published online in the Annals of the American Thoracic Society.

In “Prevalence, Characteristics and Association of Obstructive Sleep Apnea with Blood Pressure Control in Patients with Resistant Hypertension,” Esther Sapiña-Beltrán and colleagues report on a study conducted in 284 patients, ages 18 to 75, who were treated at hospitals in three countries—Spain, Singapore, and Brazil—for resistant hypertension (RH). Of all patients with high blood pressure, those with resistant hypertension, which requires three or more drugs to control, are at greatest risk for a heart attack or other cardiovascular event.

“We believe that OSA plays an important role in the pathogenesis and prognosis of patients with resistant hypertension,” says senior author Mireia Dalmases Cleries, MD, a pulmonologist and sleep researcher at the Hospital Universitari Arnau de Vilanova, in Lleida, Spain, in a release. “Our study shows a dose-response association between OSA severity and blood pressure, especially during the

Orlando 6-year-old Girl Arrested by School Resource Officer 0

Orlando 6-year-old Girl Arrested by School Resource Officer

Kaia’s arrest came after the little girl had a tantrum in class because her sleep apnea prevented her from getting enough rest the night before, reports The Washington Post.

“She has a medical condition that we’re working on getting resolved,” Kirkland said she told Turner. “So he says, ‘What medical condition?’ I said, ‘She has a sleep disorder, sleep apnea.’ He says, ‘Well, I have sleep apnea and I don’t behave like that.’ ”

from Sleep Review http://www.sleepreviewmag.com/2019/09/orlando-6-year-old-girl-arrested-school-resource-officer/…